Special Announcement - Now Screening for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for an FDA-approved stem cell clinical trial for knee arthritis. Our clinic is now screening patients for this trial. Contact us at 312-475-1893 for details. Click here to learn more.

Cellular Orthopedics Blog

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Cellular Orthopedic International Diplomacy

Cellular Orthopedic International Diplomacy

Three and a half years ago, I performed a Bone Marrow Concentrate for the arthritic hip of a visiting orthopedic surgeon, who had sought me out so as to help him postpone, perhaps avoid a joint replacement. Given professional discretion, I am unable to disclose...

read more
Reporting as Your Regenerative Medicine Town Crier

Reporting as Your Regenerative Medicine Town Crier

Last week, I received an update from Personalized Stem Cells, Inc. indicating that the trial submission to the FDA concerning a third Adipose-Derived Mesenchymal Stem Cell Study for the arthritic knee would take place in late September or early October. You may learn...

read more
Should You Repeat a Biologic Application?

Should You Repeat a Biologic Application?

As we continue to monitor outcomes from the thousands of patients treated in our offices over the last ten years, the evidence we gather tells us that outcomes improve with repeated biologic injections. We also note that outcome improvement varies, so some patients...

read more
“Don’t let the old man in”

“Don’t let the old man in”

Over the weekends this spring and summer, I have ridden my bike with other cyclists on group rides in the Driftless area of Southwest Wisconsin. The rides may last as long as three hours and cover distances ranging between 20 to 30 miles, up and down. The groups are...

read more
On Structural and Cellular Repair of Articular Defects

On Structural and Cellular Repair of Articular Defects

Under Section 361 of the Public Health Service Act, biologic products must meet the following four criteria: they are minimally manipulated; they are intended for homologous use; they do not involve a combination of cells and tissues with another article (with some...

read more
Regenerative Medicine and Stem Cells, What’s Next?

Regenerative Medicine and Stem Cells, What’s Next?

On May 31st, the FDA made it clear, that it would crack down on the charlatans, the prostitutes, and the camp followers who both fail to follow the FDA guidelines for Regenerative Medicine offerings and put the patient at potential risk. While, I am still able to use...

read more
Regenerative Medicine Reflections

Regenerative Medicine Reflections

By an Evidence-Based Cellular Orthopedic Surgeon Memorial Day has come and gone. On May 31, the FDA finally started enforcing many of its rules; and Amniotic Fluid, for the time being, is no longer considered FDA compliant. Gone too are all the other biologic...

read more
Memorial Day and Regenerative Medicine

Memorial Day and Regenerative Medicine

By an Evidence-Based Cellular Orthopedic Surgeon The Food and Drug Administration has pledged that after May 31, 2021, the agency will broadly enforce requirements that developers of regenerative medicine products — therapies intended to repair or replace damaged...

read more
Cellular Orthopedics for Osteoarthritis

Cellular Orthopedics for Osteoarthritis

From Upcoming Treatments to Treatments Yet to Come On Saturday, I graduate into yet another decade of my life’s journey. In this Blog, instead of looking back, I will look to the future. The U.S. Food and Drug Administration plays a vital role in facilitating the...

read more

Pin It on Pinterest

Share This